Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Exp Cell Res ; 332(1): 102-15, 2015 Mar 01.
Article in English | MEDLINE | ID: mdl-25557874

ABSTRACT

Activin-A and activin-B, members of the TGF-ß superfamily, are regulators of reproductive functions, inflammation and wound healing. These dimeric molecules regulate various cellular activities such as proliferation, migration and suvival. Malignant mesothelioma is an asbestos exposure related tumor affecting mainly pleura and it usually has a dismal prognosis. Here, we demonstrate that both activin-A and -B are abundantly expressed in mesothelioma tumor tissue as well as in cultured primary and established mesothelioma cells. Migratory and invasive mesothelioma cells were also found to have attenuated activation of the Smad2/3 pathway in response to activins. Migration and invasive growth of the cells in three-dimentional matrix was prevented by inhibition of activin activity using a soluble activin receptor 2B (sActR2B-Fc). This was associated with decreased ERK activity. Furthermore, migration and invasive growth was significantly inhibited by blocking ERK phosphorylation. Mesothelioma tumors are locally invasive and our results clearly suggest that acivins have a tumor-promoting function in mesothelioma through increasing expression and switching from canonical Smad3 pathway to non-canonical ERK pathway signaling. Blocking activin activity offers a new therapeutic approach for inhibition of mesothelioma invasive growth.


Subject(s)
Activins/metabolism , Cell Movement , Extracellular Signal-Regulated MAP Kinases/metabolism , Lung Neoplasms/metabolism , Mesothelioma/metabolism , Smad3 Protein/metabolism , Activin Receptors, Type I/metabolism , Activin Receptors, Type II/metabolism , Activins/genetics , Aged , Enzyme Activation , Female , Gene Expression , Humans , Lung Neoplasms/pathology , MAP Kinase Signaling System , Male , Mesothelioma/pathology , Mesothelioma, Malignant , Middle Aged , Neoplasm Invasiveness
2.
J Cell Biochem ; 113(7): 2234-47, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22573546

ABSTRACT

The inhalation of asbestos fibers is considered to be highly harmful, and lead to fibrotic and/or malignant disease. Epithelial-to-mesenchymal transition (EMT) is a common pathogenic mechanism in asbestos associated fibrotic (asbestosis) and malignant lung diseases. The characterization of molecular pathways contributing to EMT may provide new possibilities for prognostic and therapeutic applications. The role of asbestos as an inducer of EMT has not been previously characterized. We exposed cultured human lung epithelial cells to crocidolite asbestos and analyzed alterations in the expression of epithelial and mesenchymal marker proteins and cell morphology. Asbestos was found to induce downregulation of E-cadherin protein levels in A549 lung carcinoma cells in 2-dimensional (2D) and 3D cultures. Similar findings were made in primary small airway epithelial cells cultured in 3D conditions where the cells retained alveolar type II cell phenotype. A549 cells also exhibited loss of cell-cell contacts, actin reorganization and expression of α-smooth muscle actin (α-SMA) in 2D cultures. These phenotypic changes were not associated with increased transforming growth factor (TGF)-ß signaling activity. MAPK/Erk signaling pathway was found to mediate asbestos-induced downregulation of E-cadherin and alterations in cell morphology. Our results suggest that asbestos can induce epithelial plasticity, which can be interfered by blocking the MAPK/Erk kinase activity.


Subject(s)
Alveolar Epithelial Cells/drug effects , Asbestos, Crocidolite/toxicity , Epithelial Cells/drug effects , Extracellular Signal-Regulated MAP Kinases/metabolism , MAP Kinase Signaling System/drug effects , Pulmonary Alveoli/cytology , Actins/biosynthesis , Alveolar Epithelial Cells/metabolism , Alveolar Epithelial Cells/pathology , Cadherins/biosynthesis , Cell Line, Tumor , Epithelial Cells/metabolism , Epithelial-Mesenchymal Transition/drug effects , Humans , JNK Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/antagonists & inhibitors , Pulmonary Alveoli/metabolism , Pulmonary Fibrosis , Transforming Growth Factor beta/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL